Document text
Principal Investigator: Yi Ren
Organization: VANDERBILT UNIVERSITY
Fiscal Year: 2024
Award: $515,125
Funding agency: National Institute of General Medical Sciences
Project Summary
In all eukaryotic cells, export of mRNA from the nucleus to the cytoplasm is an essential step in gene
expression. As such, mRNA nuclear export is fundamental for all cellular activities and has been linked to
various diseases when it is dysregulated, such as in cancer, neurological disorders, and viral infections.
Our research focuses on elucidating the mechanisms and regulation of mRNA export under physiological
and pathological conditions. Within the nucleus, newly synthesized mRNAs are processed and packaged
with proteins to form ribonulceoprotein particles (mRNPs). The core machinery that facilitates the assembly
of export-competent mRNPs is the TREX (TRanscription/EXport) complex. Through the enzymatic activity
of its ATPase subunit Sub2/DDX39B, TREX facilitates loading of export-specific factors including the export
receptor NXF1•NXT1 to form export-competent mRNPs. We have recently elucidated the architecture of
the TREX complex and defined key steps of Sub2/DDX39B’s activity. These findings provide a solid
foundation for us moving forward to investigate fundamental aspects of mRNA export that remain poorly
understood. In this grant period, we aim to identify and structurally characterize the physical and functional
interaction network that connects different steps of mRNA export and coordinates the export process with
other nuclear events. We envision that these molecular connections spatiotemporally regulate the ATPase-
driven mRNP assembly and establish selective export of mature transcripts. The resulting biochemical and
structural knowledge will generate hypotheses that we will test at the cellular level. In addition, we aim to
investigate how viruses exploit host mRNA export to facilitate their replication. We recently have elucidated
the molecular basis for how influenza A virus and SARS-CoV-2 target NXF1•NXT1 to block host gene
expression. We will continue to study the various mechanisms that influenza A virus uses to exploit host
mRNA export factors. Together, our work will provide mechanistic insights into the mRNA export pathway
and may offer novel therapeutic opportunities for viral infections.
Terms: <2019 novel corona virus><2019 novel coronavirus><2019-nCoV><ATP phosphohydrolase><ATPase><Adenosine Triphosphatase><Architecture><Biochemical><COVID-19 virus><COVID19 virus><Cancers><Cell Function><Cell Nucleus><Cell Physiology><Cell Process><Cellular Function><Cellular Physiology><Cellular Process><CoV-2><CoV2><Complex><Cytoplasm><Disease><Disorder><Engineering / Architecture><Eukaryotic Cell><Foundations><Gene Expression><Gene Transcription><Genetic Transcription><Grant><Health><Influenza A><Influenza A virus><Influenza Viruses Type A><Influenzavirus A><Knowledge><Link><Malignant Neoplasms><Malignant Tumor><Messenger RNA><Molecular><Nervous System Diseases><Nervous System Disorder><Neurologic Disorders><Neurological Disorders><Nuclear><Nuclear Accidents><Nuclear Export><Nucleus><Orthomyxovirus Type A><Pathologic><Pathway interactions><Physiologic><Physiological><Process><Proteins><RNA Expression><Receptor Protein><Regulation><Research><SARS corona virus 2><SARS-CO-V2><SARS-COVID-2><SARS-CoV-2><SARS-CoV2><SARS-associated corona virus 2><SARS-associated coronavirus 2><SARS-coronavirus-2><SARS-related corona virus 2><SARS-related coronavirus 2><SARSCoV2><Severe Acute Respiratory Coronavirus 2><Severe Acute Respiratory Distress Syndrome CoV 2><Severe Acute Respiratory Distress Syndrome Corona Virus 2><Severe Acute Respiratory Distress Syndrome Coronavirus 2><Severe Acute Respiratory Syndrome CoV 2><Severe Acute Respiratory Syndrome-associated coronavirus 2><Severe Acute Respiratory Syndrome-related coronavirus 2><Severe acute respiratory syndrome associated corona virus 2><Severe acute respiratory syndrome coronavirus 2><Severe acute respiratory syndrome related corona virus 2><Solid><Subcellular Process><Testing><Transcript><Transcription><Type A Influenza><Viral Diseases><Virus><Virus Diseases><Virus Replication><Work><Wuhan coronavirus><coronavirus disease 2019 virus><coronavirus disease-19 virus><hCoV19><insight><mRNA><mRNA Export><mRNP><malignancy><messenger ribonucleoprotein><nCoV2><neoplasm/cancer><neurological disease><new drug treatments><new drugs><new pharmacological therapeutic><new therapeutics><new therapy><next generation therapeutics><novel drug treatments><novel drugs><novel pharmaco-therapeutic><novel pharmacological therapeutic><novel therapeutics><novel therapy><nuclear disaster><nuclear event><nuclear incident><particle><pathway><receptor><spatiotemporal><viral infection><viral multiplication><viral replication><virus infection><virus multiplication><virus-induced disease>